- This event has passed.
MOD Series 👁️ IL-6 Trans-Signaling: A Novel Therapeutic Target for Diabetic Retinopathy
December 6, 2023 @ 12:00 pm - 1:00 pm
Students & Faculty please join us for the
Mechanisms of Disease
2023-2024 SEMINAR SERIES
Presented by
Shruti Sharma, PhD
Associate Professor
Center of Biotechnology & Genomic Medicine
Department of Ophthalmology
Medical College of Georgia at Augusta University
Personal Statement:
Dr. Shruti Sharma is an Associate Professor in the Center of Biotechnology and Genomic Medicine, Department of Ophthalmology at the Medical College of Georgia at Augusta University. Her major research interests are in understanding the role of vascular dysfunction in the microvascular complications of diabetes. Currently, her lab is focused on studying the inflammation-induced pathologies in diabetic retinopathy (DR), and has established the role of interleukin-6 trans-signaling as a novel therapeutic target in DR by using the drug-sgp130Fc. Our in-vitro and animal studies have shown that this drug can prevent inflammation, oxidative stress, mitochondrial damage, and apoptosis associated with diabetic retinopathy.
Location: Russell Hall, Room 228
